Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2017 | 2014
Number of items: 3.

2017

Kebir, S., Schaefer, N., Hattingen, E., Steinbach, J., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Herrlinger, U. and Glas, M. (2017). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 74 - 75. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, S., Stummer, W., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Vatter, H., Herrlinger, U. and Glas, M. (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA. RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 112 - 113. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

2014

Herrlinger, U., Schaefer, N., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W. and Glas, M. (2014). THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

This list was generated on Fri Nov 22 19:29:21 2024 CET.